Comparative Analysis of Isolated Venous, Isolated Arterial, and Standard Access for Transcatheter Closure of Patent Ductus Arteriosus (PDA)

Not Applicable

Completed

• Conditions: Hemodynamically Significant PDA

• Registration Number: NCT06763978
• Lead Sponsor: Egyptian Biomedical Research Network

Brief Summary

We enrolled all patients with a hemodynamically significant PDA demonstrated by patient clinical condition, and by PDA size \& left chamber dilatation on echocardiography attending at Cardiology Department to we compare the use of a single venous access and a single arterial access with the standard approach requiring both venous and arterial access for transcatheter PDA closure regarding the outcome \& complications.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-01-01
• Primary Completion: 2024-01-31
• Study Completion: 2024-01-31
• Status Verified: 2025-01
• Study First Submitted: 2025-01-03
• Study First Submitted QC: 2025-01-03
• Last Update Submitted: 2025-01-03
• Study First Posted: 2025-01-08
• Last Update Posted: 2025-01-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 357

Inclusion Criteria

• any patient with hemodynamically significant PDA

Exclusion Criteria

• patient with pulmonary hypertension and Eisenmenger syndrome

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: FACTORIAL

Primary Outcome Measures

Name	Time	Method
procedural and fluoroscopy time	during the procedure

Trial Locations

Locations (1)

Tanta University; 🇪🇬 Tanta, Egypt